Monday, September 7, 2026
UK MHRA authorizes Moderna XFG Spikevax update
The UK Medicines and Healthcare products Regulatory Agency authorized Moderna's updated Spikevax COVID-19 vaccine targeting the SARS-CoV-2 XFG variant for adults and children aged six months and older. Doses will be made at the Moderna Innovation and Technology Centre in Harwell, Oxfordshire, for the NHS 2026/27 vaccination programme. The European Medicines Agency's Emergency Task Force separately recommended that 2026/2027 COVID-19 vaccines target the XFG variant.
/ Sources
/ About this story
Compiled by Venture Atlas from the sources above, using automated AI-assisted research. This is a summary of reporting published elsewhere, not original reporting - follow the source links for the full account. See our editorial standards.
Something wrong here? Email flightatlas.contact@gmail.com and we will fix it.
/ Related
- Moderna prices upsized $2.6 billion convertible notesTuesday, September 1, 2026
- FDA approves Moderna's updated 2026-2027 COVID vaccinesFriday, August 28, 2026
- Moderna to raise $2 billion in convertible senior notesThursday, August 27, 2026
- Moderna-Merck melanoma vaccine hits Phase 3 goals, shares surgeWednesday, August 19, 2026